Renal water transport in health and disease.


Journal

Pflugers Archiv : European journal of physiology
ISSN: 1432-2013
Titre abrégé: Pflugers Arch
Pays: Germany
ID NLM: 0154720

Informations de publication

Date de publication:
08 2022
Historique:
received: 24 02 2022
accepted: 19 05 2022
revised: 11 05 2022
pubmed: 10 6 2022
medline: 3 8 2022
entrez: 9 6 2022
Statut: ppublish

Résumé

Saving body water by optimal reabsorption of water filtered by the kidney leading to excretion of urine with concentrations of solutes largely above that of plasma allowed vertebrate species to leave the aquatic environment to live on solid ground. Filtered water is reabsorbed for 70% and 20% by proximal tubules and thin descending limbs of Henle, respectively. These two nephron segments express the water channel aquaporin-1 located along both apical and basolateral membranes. In the proximal tubule, the paracellular pathway accounts for at least 30% of water reabsorption, and the tight-junction core protein claudin-2 plays a key role in this permeability. The ascending limb of Henle and the distal convoluted tubule are impermeant to water and are responsible for urine dilution. The water balance is adjusted along the collecting system, i.e. connecting tubule and the collecting duct, under the control of arginine-vasopressin (AVP). AVP is synthesized by the hypothalamus and released in response to an increase in extracellular osmolality or stimulation of baroreceptors by decreased blood pressure. In response to AVP, aquaporin-2 water channels stored in subapical intracellular vesicles are translocated to the apical plasma membrane and raise the water permeability of the collecting system. The basolateral step of water reabsorption is mediated by aquaporin-3 and -4, which are constitutively expressed. Drugs targeting water transport include classical diuretics, which primarily inhibit sodium transport; the new class of SGLT2 inhibitors, which promotes osmotic diuresis and the non-peptidic antagonists of the V2 receptor, which are pure aquaretic drugs. Disturbed water balance includes diabetes insipidus and hyponatremias. Diabetes insipidus is characterized by polyuria and polydipsia. It is either related to a deficit in AVP secretion called central diabetes insipidus that can be treated by AVP analogs or to a peripheral defect in AVP response called nephrogenic diabetes insipidus. Diabetes insipidus can be either of genetic origin or acquired. Hyponatremia is a common disorder most often related to free water excess relying on overstimulated or inappropriate AVP secretion. The assessment of blood volume is key for the diagnosis and treatment of hyponatremia, which can be classified as hypo-, eu-, or hypervolemic.

Identifiants

pubmed: 35678906
doi: 10.1007/s00424-022-02712-9
pii: 10.1007/s00424-022-02712-9
pmc: PMC9338902
doi:

Substances chimiques

Aquaporin 2 0
Water 059QF0KO0R
Arginine Vasopressin 113-79-1

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

841-852

Informations de copyright

© 2022. The Author(s).

Références

Am J Physiol Renal Physiol. 2002 Dec;283(6):F1403-21
pubmed: 12388415
Am J Physiol Renal Physiol. 2013 Nov 1;305(9):F1352-64
pubmed: 24049145
Brain Res. 1980 Sep 15;197(1):256-9
pubmed: 6249457
Am J Med. 2006 Jan;119(1):71.e1-8
pubmed: 16431193
J Cell Biol. 1993 Jan;120(2):371-83
pubmed: 7678419
N Engl J Med. 2012 Dec 20;367(25):2407-18
pubmed: 23121377
Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1248-1257
pubmed: 30936153
Nat Rev Nephrol. 2021 Jan;17(1):65-77
pubmed: 33005037
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4386-91
pubmed: 10737773
Am J Physiol. 1996 Aug;271(2 Pt 2):F414-22
pubmed: 8770174
Am J Physiol. 1968 Jul;215(1):108-15
pubmed: 5659320
Biol Cell. 1989;66(1-2):59-63
pubmed: 2804460
J Cell Sci. 2010 Jun 1;123(Pt 11):1913-21
pubmed: 20460438
Ther Adv Cardiovasc Dis. 2021 Jan-Dec;15:1753944720977741
pubmed: 33435837
Endocrinology. 1982 May;110(5):1837-9
pubmed: 7075541
Nature. 1983 Mar 17-23;302(5905):253-5
pubmed: 6132339
Am J Physiol. 1987 Jan;252(1 Pt 2):H85-8
pubmed: 3812721
Am J Physiol Renal Physiol. 2007 Oct;293(4):F1166-77
pubmed: 17626156
Annu Rev Physiol. 2019 Feb 10;81:359-373
pubmed: 30742785
Physiol Rev. 2001 Jan;81(1):345-418
pubmed: 11152761
J Clin Endocrinol Metab. 2022 May 17;107(6):1727-1738
pubmed: 35137148
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5450-5
pubmed: 9144258
Neuroscience. 2000;100(3):539-47
pubmed: 11098117
Front Physiol. 2021 Feb 10;12:632886
pubmed: 33679444
N Engl J Med. 1981 Jul 30;305(5):263-6
pubmed: 7242616
J Am Soc Nephrol. 1999 Oct;10(10):2165-70
pubmed: 10505693
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):8011-6
pubmed: 20385797
Am J Physiol. 1970 Jun;218(6):1555-9
pubmed: 4315679
J Am Soc Nephrol. 2014 Oct;25(10):2376-83
pubmed: 24722436
Am J Physiol Renal Physiol. 2005 Dec;289(6):F1195-200
pubmed: 15998844
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):6037-42
pubmed: 16581908
J Gastroenterol. 2021 Jul;56(7):593-619
pubmed: 34231046
Am J Physiol Renal Physiol. 2000 Aug;279(2):F370-82
pubmed: 10919858
Trends Neurosci. 2010 Feb;33(2):76-83
pubmed: 19963290
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e672-e680
pubmed: 34480576
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11110-4
pubmed: 1722319
Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):13052-6
pubmed: 7528931
Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1013-7
pubmed: 7532304
N Engl J Med. 2017 Aug 17;377(7):644-657
pubmed: 28605608
Am J Med. 2013 Oct;126(10 Suppl 1):S1-42
pubmed: 24074529
Am J Physiol. 1988 May;254(5 Pt 2):R746-54
pubmed: 3364604
J Physiol. 2013 Apr 15;591(8):2205-19
pubmed: 23359673
J Biol Chem. 2002 Mar 22;277(12):10379-86
pubmed: 11782489
Endocrinology. 2014 Nov;155(11):4483-93
pubmed: 25157454
N Engl J Med. 2015 Apr 2;372(14):1349-58
pubmed: 25830425
Kidney Int Suppl. 1996 Dec;57:S93-9
pubmed: 8941928
Nat Rev Neurosci. 2017 Aug;18(8):459-469
pubmed: 28638120
J Biol Chem. 2003 Jun 13;278(24):21639-48
pubmed: 12660245
Exp Physiol. 2000 Mar;85 Spec No:243S-252S
pubmed: 10795928
Am J Physiol. 1995 Sep;269(3 Pt 1):C655-64
pubmed: 7573395
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8984-8
pubmed: 7522327
Am J Physiol Renal Physiol. 2006 Aug;291(2):F465-72
pubmed: 16434568
N Engl J Med. 1975 Jan 9;292(2):81-8
pubmed: 234006
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Int J Mol Sci. 2021 Nov 30;22(23):
pubmed: 34884753
Biochem Biophys Res Commun. 1992 Nov 16;188(3):1267-73
pubmed: 1280133
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18344-9
pubmed: 17101973
Nature. 1993 Feb 11;361(6412):549-52
pubmed: 8429910
J Am Soc Nephrol. 2006 Jun;17(6):1521-31
pubmed: 16641150
Int J Med Sci. 2020 Mar 15;17(7):874-880
pubmed: 32308540
Adv Ther. 2021 Dec;38(12):5721-5736
pubmed: 34693505
Int J Mol Sci. 2017 Nov 10;18(11):
pubmed: 29125546
Am J Physiol Renal Physiol. 2000 Jun;278(6):F1030-3
pubmed: 10836992
CEN Case Rep. 2022 Feb;11(1):6-10
pubmed: 34227056
Best Pract Res Clin Endocrinol Metab. 2012 Mar;26 Suppl 1:S7-15
pubmed: 22469249
N Engl J Med. 1987 Apr 23;316(17):1070-4
pubmed: 3561459
Am J Physiol Regul Integr Comp Physiol. 2016 Sep 1;311(3):R451-6
pubmed: 27335281
Drug Discov Today. 2010 Oct;15(19-20):826-41
pubmed: 20708094
Am J Physiol Cell Physiol. 2003 Jul;285(1):C96-101
pubmed: 12777254
Nephrol Dial Transplant. 2022 Jan 25;37(2):358-365
pubmed: 34390572
Am J Physiol Renal Physiol. 2020 Jan 1;318(1):F193-F203
pubmed: 31682170
J Cell Biol. 1993 Jan;120(2):359-69
pubmed: 8421053
Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10464-9
pubmed: 15231996
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9660-4
pubmed: 9689137
Handb Clin Neurol. 2021;181:239-248
pubmed: 34238460
Presse Med. 2021 Dec;50(4):104093
pubmed: 34718110
J Am Soc Nephrol. 2007 Nov;18(11):2937-44
pubmed: 17942963
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10997-1001
pubmed: 7526388
Nat Rev Dis Primers. 2019 Aug 8;5(1):54
pubmed: 31395885
Am J Physiol Renal Physiol. 2009 Jul;297(1):F10-8
pubmed: 19244407
J Am Soc Nephrol. 2016 Sep;27(9):2554-63
pubmed: 27188842
JAMA. 2007 Mar 28;297(12):1319-31
pubmed: 17384437
Nephrol Dial Transplant. 2014 Apr;29 Suppl 2:i1-i39
pubmed: 24569496
J Frailty Sarcopenia Falls. 2021 Dec 01;6(4):241-245
pubmed: 34950815
Am J Physiol. 1996 Mar;270(3 Pt 2):F548-53
pubmed: 8780259
Am J Med Sci. 2016 Nov;352(5):517-523
pubmed: 27865300
J Neurochem. 2001 May;77(4):1085-96
pubmed: 11359874
Am J Physiol Renal Physiol. 2004 Jan;286(1):F144-51
pubmed: 12965892
Sci Rep. 2017 Aug 25;7(1):9555
pubmed: 28842583
J Intern Med. 2017 Oct;282(4):284-297
pubmed: 28649750
Nephrol Dial Transplant. 2013 Aug;28(8):2058-65
pubmed: 23615760
J Clin Invest. 1999 Feb;103(4):491-6
pubmed: 10021457
J Clin Invest. 1997 Sep 1;100(5):957-62
pubmed: 9276712
Am J Physiol Renal Physiol. 2015 Feb 1;308(3):F237-43
pubmed: 25391898
J Clin Invest. 2000 Jan;105(2):215-22
pubmed: 10642600
J Am Soc Nephrol. 2008 May;19(5):1015-24
pubmed: 18272843
J Hepatol. 2021 Jun;74(6):1355-1361
pubmed: 33326814
Nat Rev Nephrol. 2021 Nov;17(11):765-781
pubmed: 34211154

Auteurs

Eric Feraille (E)

Department of Cell Physiology and Metabolism, University of Geneva, 1 Rue Michel Servet, CH-1211, Geneva 4, Switzerland. Eric.Feraille@unige.ch.
Service of Nephrology, Department of Internal Medicine, University Hospitals of Geneva, Geneva, Switzerland. Eric.Feraille@unige.ch.

Ali Sassi (A)

Department of Cell Physiology and Metabolism, University of Geneva, 1 Rue Michel Servet, CH-1211, Geneva 4, Switzerland.

Valérie Olivier (V)

Department of Cell Physiology and Metabolism, University of Geneva, 1 Rue Michel Servet, CH-1211, Geneva 4, Switzerland.
Service of Nephrology, Department of Internal Medicine, University Hospitals of Geneva, Geneva, Switzerland.

Grégoire Arnoux (G)

Department of Cell Physiology and Metabolism, University of Geneva, 1 Rue Michel Servet, CH-1211, Geneva 4, Switzerland.

Pierre-Yves Martin (PY)

Service of Nephrology, Department of Internal Medicine, University Hospitals of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH